Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)

Completed · Phase 3

Conditions studied: Asthma

In brief

The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.

Key facts

Study ID
NCT00073177
Run by
AstraZeneca
People needed
819
Starts
2003-11-01
Last updated by the study team
2016-10-25

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.